Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash $ 262,793 $ 0
Prepaid expenses 1,117,396 6,380
Total current assets 1,380,189 6,380
Deferred offering costs associated with proposed public offering   56,483
Investment held in Trust Account 977,556,354  
Total Assets 978,936,543 62,863
Current liabilities:    
Accounts payable 914,904 23,450
Accrued expenses 5,713,978 33,033
Due to related party 968,737  
Total current liabilities 7,597,619 56,483
Deferred legal fees 18,182  
Deferred underwriting commissions 34,212,500  
Derivative warrant liabilities 32,123,130  
Total liabilities 73,951,431 56,483
Commitments and Contingencies
Class A ordinary shares subject to possible redemption, $0.0001 par value; 97,750,000 and 0 shares at $10.00 per share as of September 30, 2021 and December 31, 2020, respectively 977,500,000  
Shareholders' (Deficit) Equity:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding  
Additional paid-in capital 0 22,556
Accumulated deficit (72,517,332) (18,620)
Total shareholders' (deficit) equity (72,514,888) 6,380
Total Liabilities and Shareholders' (Deficit) Equity 978,936,543 62,863
Class A Ordinary Shares    
Shareholders' (Deficit) Equity:    
Common Stock 0  
Class B Ordinary Shares    
Shareholders' (Deficit) Equity:    
Common Stock 2,444 2,444
Total shareholders' (deficit) equity $ 2,444 $ 2,444